Testing the Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Chemotherapy-Induced Peripheral Neuropathy (CIPN)

This phase II trial studies the effects of transcutaneous electrical nerve stimulation (TENS)
for the treatment of peripheral neuropathy caused by chemotherapy, often called
chemotherapy-induced peripheral neuropathy (CIPN). Peripheral neuropathy refers to the
conditions that result when nerves that carry messages to and from the brain and spinal cord
from and to the rest of the body are damaged or diseased. The TENS device emits high
frequency electrical stimulation through the skin and may provide relief from chronic pain.

Intervention

Placebo Administration, Questionnaire Administration, Transcutaneous Electrical Nerve Stimulation

Condition

Chemotherapy-Induced Peripheral Neuropathy

Investigators

Jennifer Gewandter, Gregory A. Masters, Bryan A. Faller, Kathleen J. Yost, James D. Bearden, Brian L. Burnette

See list of participating sites